ALT
Altimmune to Participate in the Leerink Global Healthcare Conference
Monday, March 3, 2025 BiopharmaWatch Research 1 min read Key Takeaway: Altimmune to Participate in the Leerink Global Healthcare Conference
Price reaction · baseline $6.65 (2025-02-28 close) · 1 other ALT headline(s) in the window, move may be shared
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+22%
120-day peak, hindsight
Typical move
10.2%
average across 8 past catalysts
Cash runway
~64 mo
Minimal dilution risk
Lead asset
ALT-801
Phase 2 · Obesity/Overweight
Full Press Release Details
Altimmune to Participate in the Leerink Global Healthcare Conference.